PACKARD BIOSCIENCE CO
S-8, EX-5., 2000-08-18
LABORATORY ANALYTICAL INSTRUMENTS
Previous: PACKARD BIOSCIENCE CO, S-8, 2000-08-18
Next: PACKARD BIOSCIENCE CO, S-8, EX-23.1, 2000-08-18





                                                                       EXHIBIT 5


                                                                 August 16, 2000


Packard BioScience Company
800 Research Parkway
Meriden, Connecticut 06450

Ladies and Gentlemen:

We have acted as counsel for Packard BioScience Company, a Delaware  corporation
(the  "Company"),  in connection  with the preparation and filing by the Company
with the Securities and Exchange Commission of a Registration  Statement on Form
S-8 (the "Registration  Statement")  pursuant to the Securities Act of 1933 (the
"Securities  Act"),  with respect to up to 1,510,440 shares of common stock, par
value  $.002  (the  "Common  Stock"),  of  the  Company,  as  described  in  the
Registration Statement.

In rendering this opinion, we have examined and relied upon originals or copies,
certified  or  otherwise   identified  to  our  satisfaction  of  such  records,
documents, certificates and other instruments including, but not limited to, (i)
the Amended and Restated  Certificate of Incorporation of the Company,  (ii) the
Bylaws of the Company,  (iii) the  Management  Stock  Incentive  Plan,  and (iv)
certain  minutes of the  corporate  proceedings  of the Board of  Directors  and
shareholders of the Company,  and have made such  investigation of law as in our
judgment  is  necessary  or  appropriate  to enable us to  render  the  opinions
expressed below.

We have assumed the authenticity of all documents  submitted to us as originals,
the genuineness of all signatures, the legal capacity of natural persons and the
conformity to the originals of all documents submitted to us as copies.

The  opinions  set forth  below  are  based on,  and  limited  to,  the  General
Corporation  Law of the State of Delaware  and no opinion is expressed as to the
laws of any other jurisdiction.

Based on and subject to the foregoing,  we are of the opinion that the shares of
Common Stock,  when issued upon the exercise of options in  accordance  with the
terms  of  the  Management  Stock  Incentive  Plan  and as  contemplated  by the
Registration  Statement,  will be duly authorized and legally issued, fully paid
and non-assessable.

We hereby consent to the filing of this opinion as Exhibit 5 to the Registration
Statement. In giving such consent, we do not hereby admit that we are within the
category of persons  whose  consent is  required by Section 7 of the  Securities
Act. This opinion is not to be used, circulated, quoted or otherwise referred to
for any other purpose without our express written consent.


                                          Very truly yours,

                                     /s/ Day, Berry & Howard LLP
                                    -----------------------------
                                       DAY, BERRY & HOWARD LLP





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission